Melanoma in Pregnancy: CLAUDIUS - a retrospective, multicenter Study to evaluate the Risk of transplacental Transmission to the unborn Child (2021) Gaiser MR, Mueller V, Erdmann M, Buehler B, Dugas-Breit S, Schatton K, Reinhardt L, et al. Conference contribution Patient-oriented Comparison of Systemic Therapies for Patients with advanced Melanoma - A multicenter Cross-sectional Study (2021) Thiem A, Mashhadiakbar P, Hassel JC, Grimmelmann I, Gutzmer R, Schlaak M, Heppt M, et al. Conference contribution Clinical Prognostic Factors in metastatic Choroidal Melanoma (2021) Koch E, Petzold A, Wessely A, Dippel E, Erdmann M, Heinzerling L, Hohberger B, et al. Conference contribution Elective Discontinuation of Checkpoint Inhibitor Therapy in Patients with advanced Melanoma (2021) Persa OD, Schatton K, Ruebben A, Berking C, Erdmann M, Schlaak M, Mauch C, Steeb T Conference contribution Long-term Effectiveness of Interventions for actinic Keratoses: Results of a systematic Review and Network Meta-Analysis (2021) Steeb T, Wessely A, Petzold A, Brinker T, Schmitz L, Lei-Ter-Stoppke U, Garbe C, et al. Conference contribution The Side Effect Registry SERIO - Side Effect Registry Immuno-Oncology - documenting, analyzing and better understanding Complex Side Effects under Immunotherapy (2021) Zierold S, Rahimi F, Kramer R, Knauss S, Tomsitz D, French LE, Heinzerling L Conference contribution Prediction and Prophylaxis of Immune Checkpoint Inhibitor-mediated Hepatitis (2021) Schilling HL, Hutchinson J, Kronenberg K, Riquelme P, Wenzel J, Glehr G, Zeman F, et al. Conference contribution Development of a digital Teaching Project on the Topic of "Immunooncology" (2021) Kaufmann M, Berking C, French LE, Meyerolbersleben M, Reinholz M, Steeb T, Heppt M Conference contribution Serositis in Association with System Therapy with Checkpoint Inhibitors - More frequent than thought? - An Evaluation of the SERIO Adverse Event Registry (2021) Zierold S, Kramer R, Erdmann M, Akcetin SL, Maier AM, Koenig A, Theurich S, et al. Conference contribution Investigation on Consequences of Autoimmunity with Regard to Quality of Life in Patients with Checkpoint Inhibitor Therapy compared to Patients with Autoimmune Disease (2021) Schulz TU, Zierold S, Akcetin SL, Pesch G, French LE, Heinzerling L Conference contribution